Advertisement
News
Advertisement

Molecular Insight waiver deal extended again

Thu, 10/07/2010 - 10:35am
Mass High Tech: The Journal of New England Technology

Molecular Insight Pharmaceuticals Inc. has again had a waiver agreement extended with its bond holders, enabling company discussions associated with debt restructuring to continue. It is the the eleventh such waiver extension and will last until Oct. 15.

The Cambridge biotechnology firm noted in a press release that it plans to review debt restructuring proposals with its bond holders during the extension period.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading